FDA Determines Regulatory Review Period for ISTENT TRABECULAR MICRO-BYPASS STENT Patent Extension

Summary

The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for the ISTENT TRABECULAR MICRO-BYPASS STENT, following a patent extension application submitted to the US Patent and Trademark Office (USPTO)